3 completed, 1 active not recruiting, 1 terminated. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Abdominal Abscess: new trials by email Literature Review of Abdominal Abscess trials Research Report on Abdominal Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abdominal aBscess Catheter Sclerotherapy (ABCS) Catheter Sclerotherapy - Abdominal Abscess | Phase 1 / Phase 2 | Active not recruiting | University of Alabama at Birmingham | 60 | 2025-12-21 | 2026-09-24 |
| Antibiotic Irrigations for Intra-Abdominal Drains Gentamicin Sulfate Inj 20mg/2ml vial for injection, Clindamycin phosphate 6 mg/1ml for injection, Placebo - Abdominal Abscess | Phase 2 | Terminated | University of Iowa | 2 | 2019-04-01 | 2026-09-03 |
| Laparoscopic Management of Periappendicular Abscess Laparoscopic appendectomy, Conservative management with percutaneous drainage - Appendicitis, Abdominal Abscess | Phase 2 | Completed | Helsinki University Central Hospital | 60 | 2011-01-01 | 2014-09-23 |
| A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 146 | 2007-10-01 | 2019-03-19 |
| Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses Alteplase, saline - Abdominal Abscess, Pelvic Abscess | Phase 2 | Completed | Kaiser Permanente | 20 | 2006-02-01 | 2015-02-26 |
Appendicitis (1) · Bacterial Infections (1) · Fever (1) · Ileus (1) · Pneumonia (1) · Pneumonia, Bacterial (1) · Pneumonia, Ventilator-Associated (1)
Abscess (5) · Infections (5) · Suppuration (5) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Bacterial Infections and Mycoses (1) · Body Temperature Changes (1) · Cecal Diseases (1) · Cross Infection (1) · Disease Attributes (1) · Gastroenteritis (1) · Healthcare-Associated Pneumonia (1) · Iatrogenic Disease (1) · Intestinal Obstruction (1)
Cilastatin, Imipenem Drug Combination (1) · Conservative Treatment (1) · Doripenem (1) · Injections (1) · Sodium Chloride (1) · Tissue Plasminogen Activator (1) · clindamycin phosphate (1)
Helsinki University Central Hospital (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Kaiser Permanente (1) · University of Alabama at Birmingham (1) · University of Iowa (1)
United States (3) · Finland (1)
Hyo-Chun Yoon, MD, PhD (1) · Junaid Raja, MD, MSPH, FACP (1) · Panu Mentula, M.D. Ph.D. (1) · Scott Sherman, MD (1)